Cargando…
Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy
BACKGROUND: International HIV guidelines have recently shifted from a medium-late to an early-start treatment strategy. As a consequence, more people will be eligible to Highly Active Antiretroviral Therapy (HAART). We estimate mean life years gained using different treatment indications in low inco...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836271/ https://www.ncbi.nlm.nih.gov/pubmed/20180966 http://dx.doi.org/10.1186/1742-6405-7-3 |